202825-45-4,
(S)-2-((4-((2-Fluorobenzyl)oxy)benzyl)amino)propanamide methanesulfonate,
RALFINAMIDE MESYLATE,
(S)-2-((4-((2-Fluorobenzyl)oxy)benzyl)-amino)propanamide methanesulfonate,
(2S)-2-[[[4-[(2-FLUOROPHENYL)METHOXY]PHENYL]METHYL]AMINO]-PROPANAMIDE METHANESULFONATE,
MLS006010674,
SCHEMBL1697241,
CTK8B9097,
DTXSID80635374,
CHQVNINIGBRKGZ-YDALLXLXSA-N,
0394AB,
ANW-62015,
AKOS016004924,
API0010268,
Ralfinamide mesylate, >=98% (HPLC),
SMR004701656,
AX8234099,
RT-023955,
B7569,
(S)-2-[4-(2-fluorobenzyloxy)benzylamino]propanamide methanesulfonate,
(2S)-2-[[4-[(2-fluorophenyl)methoxy]phenyl]methylamino]propanamide; methanesulfonic acid,
Methanesulfonic acid--N~2~-({4-[(2-fluorophenyl)methoxy]phenyl}methyl)-L-alaninamide (1/1),
Propanamide, 2-[[[4-[(2-fluorophenyl)methoxy]phenyl]methyl]amino]-, (2S)-, methanesulfonate (1:1),
Ralfinamide,
C18H23FN2O5S,
CB12082,